DLA Piper Seeks $350K For Tyrogenex Suit Deal In Chancery

By Rose Krebs (August 23, 2021, 3:47 PM EDT) -- DLA Piper is seeking $350,000 in attorney fees for a $1.5 million proposed settlement to end a proposed class action in Delaware Chancery Court related to an alleged improper scheme to gain control of drug developer Tyrogenex Inc. and push out its founder-CEO.

In a brief submitted to Vice Chancellor J. Travis Laster last week, DLA Piper LLP asserted the proposed deal and the attorney fees and expenses being sought are fair and reasonable. The settlement is set to be considered by the court next month, according to the brief.

"There is ample precedent of fee awards consistent with or greater...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!